Inventor
ORSOLINI PIERO
CH17 patents
⚠️ This page may combine multiple inventors who share the name “ORSOLINI PIERO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DEBIO RECH PHARMA SA
9 patentsUS5776885AJul 7, 1998
Sustained and controlled release of water insoluble polypeptides
DEBIO RECH PHARMA SA117 citations98
US5445832AAug 29, 1995
Process for the preparation of microspheres made of a biodegradable polymeric material
DEBIO RECH PHARMA SA170 citations98
US5439688AAug 8, 1995
Process for preparing a pharmaceutical composition
DEBIO RECH PHARMA SA109 citations97
US6660810B1Dec 9, 2003
Non cross-linked block polyetherester, preparation and uses
DEBIO RECH PHARMA SA21 citations92
US6319512B1Nov 20, 2001
Implants for controlled release of pharmaceutically active principles and method for making same
DEBIO RECH PHARMA SA43 citations90
US6245346B1Jun 12, 2001
Pharmaceutical compositions for the sustained release of insoluble active principles
DEBIO RECH PHARMA SA18 citations90
US5431348AJul 11, 1995
Ultracentrifugal disintegrator and its use for the cryocomminution of heat sensitive material
DEBIO RECH PHARMA SA20 citations88
US6777002B1Aug 17, 2004
Process for microencapsulation of water soluble substances
DEBIO RECH PHARMA SA16 citations77
US6790942B1Sep 14, 2004
Biologically active conjugates having a detectable reporter moiety and method of identification of the derivative
DEBIO RECH PHARMA SA4 citations61
DEBIOPHARM SA
7 patentsUS5192741AMar 9, 1993
Sustained and controlled release of water insoluble polypeptides
DEBIOPHARM SA236 citations98
US5286637AFeb 15, 1994
Biologically active drug polymer derivatives and method for preparing same
DEBIOPHARM SA246 citations97
US5134122AJul 28, 1992
Method for preparing a pharmaceutical composition in the form of microparticles
DEBIOPHARM SA139 citations97
US5225205AJul 6, 1993
Pharmaceutical composition in the form of microparticles
DEBIOPHARM SA110 citations96
US4835139AMay 30, 1989
Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases
DEBIOPHARM SA70 citations96
US5187150AFeb 16, 1993
Polyester-based composition for the controlled release of polypeptide medicinal substances
DEBIOPHARM SA23 citations89
US4673595AJun 16, 1987
Microencapsulation by phase separation of water-soluble medicaments
DEBIOPHARM SA13 citations73